DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10606244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

  2005cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex.

  1999cited by this paper
• Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

  1998cited by this paper
• Identification of a Novel Bone Morphogenetic Protein-responsive Gene That May Function as a Noncoding RNA*

  1998cited by this paper
• Prostate-specific membrane antigen and other prostatic tumor markers on the horizon.

  1997cited by this paper
• Prostate-specific antigen as a screening test. The Netherlands experience.

  1997cited by this paper
• bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA

  1997cited by this paper
• Prostate-specific antigen as a screening test. The Austrian experience.

  1997cited by this paper
• New perspectives in the treatment of prostate cancer.

  1997cited by this paper
• PROSTATE-SPECIFIC ANTIGEN: Its Discovery and Biochemical Characteristics

  1997cited by this paper
• Cancer statistics, 1997

  1997cited by this paper
• Evolutionary conservation of putative functional domains in the human homolog of the murine His-1 gene.

  1997cited by this paper
• Use of prostate-specific antigen, Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer.

  1997cited by this paper
• Prostate-specific antigen as a screening test for prostate cancer. The United States experience.

  1997cited by this paper
• Interpreting cDNA sequences: Some insights from studies on translation

  1996cited by this paper
• The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.

  1995cited by this paper
• Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

  1995cited by this paper
• A novel synapse-associated noncoding RNA

  1994cited by this paper
• Retroviral insertions in the murine His-1 locus activate the expression of a novel RNA that lacks an extensive open reading frame

  1994cited by this paper
• Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern‐blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies

  1993cited by this paper
• The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus.

  1992cited by this paper
• The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus.

  1992cited by this paper
• Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.

  1992cited by this paper
• Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.

  1991cited by this paper
• Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach.

  1991cited by this paper
• The product of the H19 gene may function as an RNA

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Molecular cloning : a laboratory manual. Cold Spring Harbor, NY

  1989cited by this paper
• The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.

  1987cited by this paper

• Immunotherapeutic Strategies for Prostate Cancer: A Comprehensive Review

  2026cites this paper
• Noncoding RNA in Clinical Trials: Diagnostic and Therapeutical Prospects.

  2026cites this paper
• Prostate cancer associated 3 (PCA3) is a potential indicator of the pathological grades of prostate cancer.

  2026cites this paper
• Urinary miR-191-5p levels are significantly reduced after radical prostatectomy in patients with prostate cancer

  2026cites this paper
• From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis.

  2026cites this paper
• PROTAC technology for prostate cancer treatment.

  2025cites this paper
• A sensitive and specific non-invasive urine biomarker panel for prostate cancer detection

  2025cites this paper
• Differentiation of high risk prostate cancer with a facile urinary exosome detection workflow

  2025cites this paper
• SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance

  2025cites this paper
• Prostate Biopsy: Is it Still Relevant Today?

  2025cites this paper
• Point-of-Care Detection of Prostate Cancer Biomarkers PCA3, HOXC6, and KLK3 Using an ISFET Lab-on-Chip Platform

  2025cites this paper
• Mechanisms and progress of LncRNAs in prostate cancer development and diagnostic therapy

  2025cites this paper
• The Impact of Urine Biomarkers for Prostate Cancer detection - A Systematic State of the Art Review.

  2025cites this paper
• Upregulation of long noncoding RNAs LINC00941 and ABHD11-AS1 is associated with intrahepatic cholangiocarcinoma

  2025cites this paper
• Urinary Markers for Prostate Cancer: State of the Art

  2025cites this paper
• Unveiling Racial Disparities in Localized Prostate Cancer: A Systems-Level Exploration of the lncRNA Landscape

  2025cites this paper
• New biomarkers and multiplex tests for diagnosis of aggressive prostate cancer and therapy management

  2025cites this paper
• Effects of Non-Coding RNAs in Prostate Cancer: Diagnosis, Prognosis, and Therapy

  2025cites this paper
• Exploring the potential of BOLA3-DT as a diagnostic biomarker in prostate cancer

  2025cites this paper
• Advances in cancer detection: A review on electrochemical biosensor technologies

  2025cites this paper
• Current and emerging tissue‐based molecular biomarkers for prostate cancer management: A narrative review

  2024cites this paper
• The roles and mechanisms of coding and noncoding RNA variations in cancer

  2024cites this paper
• Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC)

  2024cites this paper
• Designing a Simple Electrochemical Genosensor for the Detection of Urinary PCA3, a Prostate Cancer Biomarker

  2024cites this paper
• Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs.

  2024cites this paper
• snRNAs from Radical Prostatectomy Specimens Have the Potential to Serve as Prognostic Factors for Clinical Recurrence after Biochemical Recurrence in Patients with High-Risk Prostate Cancer

  2024cites this paper
• Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer

  2024cites this paper
• Roles of Long Noncoding RNA in Prostate Cancer Pathogenesis.

  2024cites this paper
• Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer

  2024cites this paper
• Potential value of Prostate Cancer Antigen 3 score in prediction of final cancer pathology parameters in radical prostatectomy patients

  2024cites this paper
• Potential markers of prostate cancer in urine

  2024cites this paper
• Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia

  2024cites this paper
• Multiplexed quantitative proteomics in prostate cancer biomarker development.

  2024cites this paper
• From microscopes to molecules: The evolution of prostate cancer diagnostics

  2024cites this paper
• CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds

  2024influential citation
• Rho GTPase activating protein 21-mediated regulation of prostate cancer associated 3 gene in prostate cancer cell

  2024cites this paper
• Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects

  2024cites this paper
• Long non-coding RNAs: regulators of autophagy and potential biomarkers in therapy resistance and urological cancers

  2024cites this paper
• The Expression of LINC00673 in Colon Cancer and the Melatonin's Effect on Its Expression

  2023cites this paper
• Hsa_circ_0001944 enhanced GSPT1 expression via sponging miR‐498 to promote proliferation and invasion of gastric cancer

  2023cites this paper
• Clinical Biofluid Assays for Prostate Cancer

  2023cites this paper
• Biomarkers for Prostate Cancer: From Diagnosis to Treatment

  2023cites this paper
• The dynamic role of platelets in cancer progression and their therapeutic implications

  2023cites this paper
• Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases

  2023cites this paper
• Biological roles of A-to-I editing: implications in innate immunity, cell death, and cancer immunotherapy

  2023cites this paper
• Genome-wide studies in prostate cancer poised liquid biopsy as a molecular discovery tool

  2023cites this paper
• Long non-coding RNAs in bone metastasis: progresses and perspectives as potential diagnostic and prognostic biomarkers

  2023cites this paper
• Variations in genomic regions encoding long non-coding RNA genes associated with increased prostate cancer risk.

  2023cites this paper
• The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer

  2023influential citation
• Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer

  2023cites this paper
• The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer.

  2023cites this paper
• Targeting long noncoding RNAs in neuroblastoma: Progress and prospects

  2023cites this paper
• Long non-coding RNA SOX21-AS1: A potential tumor oncogene in human cancers.

  2023cites this paper
• Clinical importance of PCA3 lncRNA aberrant expression in chronic myeloid leukemia patients: a comparative method

  2023cites this paper
• MIMT1 and LINC01550 are uncharted lncRNAs down‐regulated in colorectal cancer

  2023cites this paper
• ADAR1-Mediated RNA Editing and Its Role in Cancer

  2022cites this paper
• Detection of Prostate Cancer Biomarker PCA3 by using Aptasensors.

  2022cites this paper
• Review of commercially available biomarkers in the diagnosis of prostate cancer

  2022cites this paper
• Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts

  2022cites this paper
• Glycation-Associated Diabetic Nephropathy and the Role of Long Noncoding RNAs

  2022cites this paper
• Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer

  2022cites this paper
• Emerging role of oncogenic long noncoding RNA as cancer biomarkers

  2022cites this paper
• Understanding of PSA biology, factors affecting PSA detection, challenges, various biomarkers, methods, and future perspective of prostate cancer detection and diagnosis

  2022cites this paper
• Unravelling the role of long non-coding RNAs in prostate carcinoma

  2022cites this paper
• Long Noncoding RNAs in Human Cancer and Apoptosis.

  2022cites this paper
• Development of Electrochemical Biosensor for miR204-Based Cancer Diagnosis

  2022cites this paper
• Urinary PCA3 a Superior Diagnostic Biomarker for Prostate Cancer among Ghanaian Men

  2022cites this paper
• DIAGNOSTIC POTENTIAL VALUE OF CIRCULATING PCA3 mRNA IN PLASMA AND URINE OF PROSTATE CANCER PATIENTS

  2022cites this paper
• Liquid biomarkers for early detection of prostate cancer and summary of available data for their use in African-American men

  2022cites this paper
• Effective Diagnosis of Prostate Cancer Based on mRNAs From Urinary Exosomes

  2022cites this paper
• LncRNA Biomarkers of Inflammation and Cancer.

  2022cites this paper
• A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer.

  2022cites this paper
• Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

  2022cites this paper
• The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches

  2022cites this paper
• Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities

  2022influential citation
• Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options

  2022influential citation
• Long non‐coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer

  2022cites this paper
• Circulating tumor cells and DNAs in prostate tumors

  2022cites this paper
• Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis.

  2022cites this paper
• Machine Learning Techniques in Prostate Cancer Diagnosis According to Prostate-Specific Antigen Levels and Prostate Cancer Gene 3 Score

  2021cites this paper
• Blood and urine biomarkers in prostate cancer: Are we ready for reflex testing in men with an elevated prostate-specific antigen?

  2021cites this paper
• Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization

  2021cites this paper
• Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics.

  2021cites this paper
• Design and Implementation of the Modern Men’s Health Center: A Multidisciplinary Approach

  2021cites this paper
• Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review

  2021cites this paper
• Comparison of the Metastasis Predictive Potential of mRNA and Long Non-Coding RNA Profiling in Systemically Untreated Breast Cancer

  2021cites this paper
• Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry

  2021cites this paper
• Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine

  2021cites this paper
• Current Trends in Prevalence and Role of Long Noncoding RNA and Gene Fusion in Prostate Cancer: An Overview

  2021cites this paper
• Circulating RNAs in prostate cancer patients.

  2021cites this paper
• LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors.

  2021cites this paper
• Urine as a Source of Liquid Biopsy for Cancer

  2021cites this paper
• Prostate cancer and microfluids – Current status and Future applications

  2021cites this paper
• Future perspective of focal therapy for localized prostate cancer

  2021cites this paper
• The journey of noncoding RNA from bench to clinic

  2021cites this paper
• Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities

  2021cites this paper
• Reference-free transcriptome signatures for prostate cancer prognosis

  2021cites this paper
• Prostate cancer and microfluids.

  2021cites this paper
• Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay

  2021cites this paper
• Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications

  2021cites this paper